At the news
? NEUTRALIMPACT 4/10 8-K filed Mar 3, 2026 at 08:38 ET
SRx Health Solutions obtained waivers from existing investors to proceed with a new preferred stock offering (Series B), allowing the company to issue new securities and waive existing participation rights. The Series B Preferred Stock will rank pari passu with the existing Series A Preferred Stock in terms of dividend and liquidation preferences.
- SRx Health Solutions entered into limited waiver and consent agreements with existing investors to permit a new securities offering (New Offering).
- The New Offering involves the issuance of Series B Preferred Stock and related warrants to new accredited investors.
- Existing investors waived their right of participation in the New Offering and any subsequent placements.
- Certain existing investors, as Required Holders, consented to the Series B Preferred Stock ranking pari passu with the Series A Preferred Stock regarding dividends, distributions, and liquidation preferences.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access